IE39516B1 - Corticoid-containing inhalant preparations - Google Patents

Corticoid-containing inhalant preparations

Info

Publication number
IE39516B1
IE39516B1 IE1292/74A IE129274A IE39516B1 IE 39516 B1 IE39516 B1 IE 39516B1 IE 1292/74 A IE1292/74 A IE 1292/74A IE 129274 A IE129274 A IE 129274A IE 39516 B1 IE39516 B1 IE 39516B1
Authority
IE
Ireland
Prior art keywords
corticoid
compositions
june
carrier
containing inhalant
Prior art date
Application number
IE1292/74A
Other languages
English (en)
Other versions
IE39516L (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IE39516L publication Critical patent/IE39516L/xx
Publication of IE39516B1 publication Critical patent/IE39516B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IE1292/74A 1973-06-23 1974-06-20 Corticoid-containing inhalant preparations IE39516B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2332663A DE2332663C2 (de) 1973-06-23 1973-06-23 Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie

Publications (2)

Publication Number Publication Date
IE39516L IE39516L (en) 1974-12-23
IE39516B1 true IE39516B1 (en) 1978-10-25

Family

ID=5885228

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1292/74A IE39516B1 (en) 1973-06-23 1974-06-20 Corticoid-containing inhalant preparations

Country Status (13)

Country Link
JP (1) JPS6245846B2 (zh)
BE (1) BE816709A (zh)
DD (1) DD112437A5 (zh)
DE (1) DE2332663C2 (zh)
DK (1) DK337574A (zh)
ES (1) ES427480A1 (zh)
FR (1) FR2233987B1 (zh)
GB (1) GB1479488A (zh)
IE (1) IE39516B1 (zh)
IL (1) IL45087A (zh)
NL (1) NL184724C (zh)
SE (1) SE7408091L (zh)
ZA (1) ZA744022B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE2829953A1 (de) * 1978-07-03 1980-01-24 Schering Ag Pharmazeutische zubereitung zur behandlung der kolitis ulcerosa und kolitis granulomatosa
US5215979A (en) * 1985-12-19 1993-06-01 Aktiebolaget Draco 16,17-acetalsubstituted pregnane 21-oic acid derivatives
US7858650B2 (en) 2004-10-22 2010-12-28 Ono Pharmaceutical Co., Ltd. Medicinal composition for inhalation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB799902A (en) * 1954-08-11 1958-08-13 Merck & Co Inc Therapeutic preparations
US3320125A (en) * 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
BE787100A (fr) * 1971-08-06 1973-02-02 Beecham Group Ltd Composition pour le traitement de l'asthme
DD95565B1 (de) * 1971-10-04 1986-10-29 Schering Ag Verfahren zur herstellung neuer pregnansaeurederivate
DE2150268C3 (de) * 1971-10-04 1980-11-06 Schering Ag, 1000 Berlin Und 4619 Bergkamen Pregnansäure-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2264003C2 (de) * 1972-12-22 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2319479C2 (de) * 1973-04-14 1982-10-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
BE816709A (fr) 1974-12-23
SE7408091L (zh) 1974-12-23
NL7408421A (zh) 1974-12-30
DK337574A (zh) 1975-03-17
ES427480A1 (es) 1976-07-16
DE2332663A1 (de) 1975-01-16
NL184724B (nl) 1989-05-16
IE39516L (en) 1974-12-23
JPS5047967A (zh) 1975-04-28
GB1479488A (en) 1977-07-13
NL184724C (nl) 1989-10-16
JPS6245846B2 (zh) 1987-09-29
AU7042174A (en) 1976-01-08
ZA744022B (en) 1975-06-25
FR2233987A1 (zh) 1975-01-17
IL45087A (en) 1978-04-30
FR2233987B1 (zh) 1977-07-08
DD112437A5 (zh) 1975-04-12
DE2332663C2 (de) 1986-07-31
IL45087A0 (en) 1974-09-10

Similar Documents

Publication Publication Date Title
KR950014073A (ko) 이소퀴놀린
CH656877A5 (de) Optisch aktive oder racemische prostaglandinderivate.
JPS6475484A (en) 4-aminopyridine derivative and acid addition salt thereof
IE39516L (en) Corticoid-containing inhalant preparations
IE36607B1 (en) A propionamide derivative a method of making it and therapeutic compositions containing it
DE3061127D1 (en) Peptides having ubiquitin-like activity, process for their preparation, therapeutic compositions containing them and their use
IE36120B1 (en) New pregnane acid derivatives
KR940007001A (ko) 새로운 n-신나모일-2-메틸-5-메톡시-3-인돌 아세트산 에스테르, 그 제조방법 및 이를 함유하는 약학적 제제
US3634407A (en) Heavy metal complexes of trihydroxamic acids
GB1510841A (en) Derivatives of 11-hydroxytestosterone processes for preparing them and uses for them
IE40585B1 (en) (naphthoylamino-alkylphenoxy)-alkyl-carboxylic acid derivatives
IE40477L (en) Androstane derivatives.
GB1399261A (en) 1,3-diamino 2-propanols and process for their preparation
GB1474749A (en) Pharmaceutical preparations based on cyproterone
IE43117L (en) Naphthacene derivatives
JPS5585520A (en) Remedy for peptic ulcer
IE41349B1 (en) A 4,5-azimidobenzamide derivative
EP0124252A3 (en) Double ester of 16beta-ethylestran-17beta-ol derivatives
IE44230L (en) 1, 3-diaza-bicyclo [3,2, 0] heptane derivatives
JPS54128583A (en) Thiosemicarbazone derivative
IE37504B1 (en) Preparation of n-(tertiary aminoalkyl)-2-alkoxy benzamides and novel benzoic anhydride derivatives produced during it
JPS56125357A (en) Cyclic compound and its preparation
GB1363150A (en) 17alpha-propadienyl steroids
JPS55133400A (en) 24,24-difluorocholesterol derivative and its preparation
Adapa et al. 179. Metabolic products of microorganisms. 216. Report. Isolation, structure determination and synthesis of ferrioxamin H.